In terms of ovarian cancer, overexpression of miR-200c in an ovarian cancer cell line (Hey8A) decreased IL8 and CXCL1 expressions and this suppression was reversed by the presence of miR-200c inhibitors (Pecot et al., 2013). The gene discussed is CXCL1; the disease is ovarian carcinoma.